These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24098667)

  • 1. Association of survivin polymorphisms with tumor susceptibility: a meta-analysis.
    Zhu Y; Li Y; Zhu S; Tang R; Liu Y; Li J
    PLoS One; 2013; 8(9):e74778. PubMed ID: 24098667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.
    Xu L; Zhou X; Xu L; Yin R
    Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.
    Li Y; Wang J; Jiang F; Lin W; Meng W
    BMC Med Genet; 2012 Jan; 13():1. PubMed ID: 22214342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Survivin rs9904341 and rs17878467 Polymorphisms On Risk of Preeclampsia in Iran.
    Salimi S; Zaki-Dizaji M; Shafiee A; Saravani M; Jafarabady K; Ghasemi M; Norozi M; Heidary Z
    Biochem Genet; 2024 Jun; 62(3):2134-2147. PubMed ID: 37864584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
    Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility.
    Xu W; Jiang S; Xu Y; Chen B; Li Y; Zong F; Zhao W; Wu J
    PLoS One; 2012; 7(5):e37443. PubMed ID: 22616010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
    Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
    Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects.
    Xu M; Hu X; Zhang M; Ge Y
    Gene; 2020 Apr; 733():144268. PubMed ID: 31809840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Song Y; Yang Y; Liu L; Liu X
    Gene; 2019 May; 698():186-197. PubMed ID: 30849545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
    Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
    Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
    Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2012 Jan; 39(1):81-7. PubMed ID: 21553228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis.
    Lee YH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2012 Jan; 39(1):319-26. PubMed ID: 21553055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
    Mazoochi T; Karimian M; Ehteram H; Karimian A
    Per Med; 2019 Jan; 16(1):67-78. PubMed ID: 30465472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
    Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
    World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.
    Xu W; Xu J; Liu S; Chen B; Wang X; Li Y; Qian Y; Zhao W; Wu J
    PLoS One; 2011; 6(5):e20471. PubMed ID: 21637771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.